Dense Deposit Disease - 6 Studies Found

Withdrawn : Sulodexide Treatment in Patients With Dense Deposit Disease
: Dense Deposit Disease
: 2007-12-20
: Drug: Sulodexide 200 mg per day in an oral gelcap form
Withdrawn : Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy
:
  • Dense Deposit Disease
  • Membranoproliferative Glomerulonephritis<
    : 2010-10-13
    : Drug: Eculizumab 900 mg IV once a week x 4 weeks, 1200 mg
Terminated : Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease
:
  • Dense Deposit Disease
  • Membranoproliferati
    : 2013-01-29
    : Drug: CDX-1135 Other Names:
    • TP10
    • sCR1
Withdrawn : TP10 Use in Patients With C3 Glomerulopathy (C3G)
: Dense Deposit Disease
: 2014-11-05
: Drug: TP10 All patients will be enrolled through the University of Iowa. This study will follow a patien
Recruiting : Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721
:
  • IgAN
  • Lupus Nephritis
  • MN

  • : 2016-02-10
    :
    • Biological: OMS721 Biological:
Not yet recruiting : A Proof-of-Mechanism Study to Determine the Effect of ACH-0144471 on C3 Levels in Patients With C3G or IC-MPGN
:
  • C3 Glomerulonephritis
  • Dense Deposit Disease